# LifeSouth Community Blood Centers, Inc, Gainesville, FL – FDA Inspections

Source: https://www.keypedia.com/companies/lifesouth-community-blood-centers-inc/94ebe4e9-b648-4d51-a063-4ad00b617893

> Inspection records and compliance data for LifeSouth Community Blood Centers, Inc in Gainesville, Florida. 12 FDA inspections on record, 3 Form 483s, last inspected May 21, 2026.

---

## Details

- Name: LifeSouth Community Blood Centers, Inc
- FEI Number: 3003707120
- Address Line 1: 4039 Newberry Rd
- City: Gainesville
- State: Florida
- Zip Code: 32607
- Country Name: United States
- Address: 4039 Newberry Rd, Gainesville, Florida 32607, United States
- Country: United States

## Related Documents

- [483 - LifeSouth Community Blood Centers, Inc - Unknown Date](https://www.keypedia.com/records/483/lifesouth-community-blood-centers-inc/9fe1dec7-454d-4715-998f-20ad17e35deb) — source: FDA, date: Invalid Date
- [483 - LifeSouth Community Blood Centers, Inc - 2026-05-21](https://www.keypedia.com/records/483/lifesouth-community-blood-centers-inc/cbf7e30a-71d0-4c10-9993-ac0ae31235eb) — source: FDA, date: May 21, 2026
- [FDA Inspection 1318144 - LifeSouth Community Blood Centers, Inc - 2026-05-21](https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/f716ca28-69a4-4cc1-a00f-f2dc7707e64c) — source: FDA, date: May 21, 2026
- FDA Inspection 1250489 - LifeSouth Community Blood Centers, Inc - 2024-09-12 — source: FDA, date: September 12, 2024
- FDA Inspection 1250489 - LifeSouth Community Blood Centers, Inc - 2024-09-12 — classification: No Action Indicated (NAI), source: FDA, date: September 12, 2024
- [FDA Inspection 1222388 - LifeSouth Community Blood Centers, Inc - 2023-11-09](https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/81245d9f-6f14-43af-b7b4-4a37f4a1e837) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2023
- FDA Inspection 1222388 - LifeSouth Community Blood Centers, Inc - 2023-11-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2023
- FDA Inspection 1180902 - LifeSouth Community Blood Centers, Inc - 2022-09-08 — classification: No Action Indicated (NAI), source: FDA, date: September 8, 2022
- FDA Inspection 1180902 - LifeSouth Community Blood Centers, Inc - 2022-09-08 — classification: No Action Indicated (NAI), source: FDA, date: September 8, 2022
- FDA Inspection 1180902 - LifeSouth Community Blood Centers, Inc - 2022-09-08 — classification: No Action Indicated (NAI), source: FDA, date: September 8, 2022
- [483 - LifeSouth Community Blood Centers, Inc - 2020-02-27](https://www.keypedia.com/records/483/lifesouth-community-blood-centers-inc/17812fbf-51ac-42d6-b4de-ff8f31b86ce8) — source: FDA, date: February 27, 2020
- FDA Inspection 1122323 - LifeSouth Community Blood Centers, Inc - 2020-02-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 27, 2020
- [483 - LifeSouth Community Blood Centers, Inc - 2018-07-24](https://www.keypedia.com/records/483/lifesouth-community-blood-centers-inc/74eb86f0-4cfd-4582-9a59-c27e4e92836f) — source: FDA, date: July 24, 2018
- [FDA Inspection 1061834 - LifeSouth Community Blood Centers, Inc - 2018-07-24](https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/510c53e9-312b-4eab-b8c4-f89fc33beb30) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 24, 2018

## Related Companies

- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f969afa9-62d8-4cde-8873-48180823df9b)
- [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.](https://www.keypedia.com/companies/octapharma-pharmazeutika-produktionsgesellschaft-mbh/36184852-dad7-4350-8b6f-36d4527ba46f)
- [GlaxoSmithKline Vaccines Srl](https://www.keypedia.com/companies/glaxosmithkline-vaccines-srl/3b442668-2065-481f-bc35-a803bb376acc)
- [Octapharma AB](https://www.keypedia.com/companies/octapharma-ab/5a456872-4ca6-4418-b006-6e7e219ec262)
- [Humacyte Global Inc](https://www.keypedia.com/companies/humacyte-global-inc/74158903-037d-4b32-a3b5-6c90f73f3f1f)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/4611dabc-52f7-4b4a-96bf-4196e34a7c2b)
- [Kamada - Production Plant](https://www.keypedia.com/companies/kamada-production-plant/d3a7a962-b08c-4278-8951-5cad5bcfed41)
- [Dendreon Pharmaceuticals LLC](https://www.keypedia.com/companies/dendreon-pharmaceuticals-llc/68ccd67e-0a3a-41cb-ae30-e9e10a6eaef5)
- [MassBiologics](https://www.keypedia.com/companies/massbiologics/fa584e7c-22de-470c-836a-dd3028fae600)
- [Regenerative Processing Plant, LLC](https://www.keypedia.com/companies/regenerative-processing-plant-llc/9460f9cb-85fa-400b-9e07-36e5b2a73133)

## Related Officers

- [National Expert, Pharmaceutical](https://www.keypedia.com/people/simone-e-pitts/e405f1fc-4aff-4202-b216-ddbdc342d108)
- [investigator](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Mercy O Quagraine](https://www.keypedia.com/people/mercy-o-quagraine/c199b205-0142-43a0-ac9e-965aabf42265)
- [investigator](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)
